PT817635E - Utilizacao de compostos de tiazepina e oxazepina para a inibicao do vih, herpesvirus e supressores do sitema imunitario - Google Patents
Utilizacao de compostos de tiazepina e oxazepina para a inibicao do vih, herpesvirus e supressores do sitema imunitarioInfo
- Publication number
- PT817635E PT817635E PT96903713T PT96903713T PT817635E PT 817635 E PT817635 E PT 817635E PT 96903713 T PT96903713 T PT 96903713T PT 96903713 T PT96903713 T PT 96903713T PT 817635 E PT817635 E PT 817635E
- Authority
- PT
- Portugal
- Prior art keywords
- herpesvirus
- hiv
- tiazepine
- suppressors
- inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/408,431 US5612330A (en) | 1994-03-07 | 1995-03-22 | Methods for inhibiting and controlling viral growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT817635E true PT817635E (pt) | 2004-10-29 |
Family
ID=23616271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96903713T PT817635E (pt) | 1995-03-22 | 1996-01-26 | Utilizacao de compostos de tiazepina e oxazepina para a inibicao do vih, herpesvirus e supressores do sitema imunitario |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5612330A (pt) |
| EP (1) | EP0817635B1 (pt) |
| JP (1) | JPH11502814A (pt) |
| AT (1) | ATE269084T1 (pt) |
| CA (1) | CA2211179A1 (pt) |
| DE (1) | DE69632726T2 (pt) |
| DK (1) | DK0817635T3 (pt) |
| ES (1) | ES2222477T3 (pt) |
| MX (1) | MX9705709A (pt) |
| PT (1) | PT817635E (pt) |
| WO (1) | WO1996029077A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612330A (en) * | 1994-03-07 | 1997-03-18 | Warner-Lambert Company | Methods for inhibiting and controlling viral growth |
| US6218103B1 (en) * | 1997-04-16 | 2001-04-17 | Arch Development Corporation | Herpes simplex virus US3 and ICP4 as inhibitors of apoptosis |
| CA2227688C (en) | 1998-01-16 | 2007-07-31 | James W. Critchfield | Methods and compositions for inhibition of viral replication |
| US7015212B1 (en) | 1999-05-12 | 2006-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Thiazepine inhibitors of HIV-1 integrase |
| AU2001281142A1 (en) * | 2000-08-16 | 2002-02-25 | Japan Tobacco Inc. | Diazepinones as antiviral agents |
| AU2005243439B2 (en) * | 2004-05-17 | 2011-09-29 | Tibotec Pharmaceuticals Ltd. | 1-heterocyclyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| EP1961757B1 (en) | 2004-09-17 | 2010-09-01 | IDENIX Pharmaceuticals, Inc. | Phosphoindoles as HIV inhibitors |
| US7674822B2 (en) | 2004-11-24 | 2010-03-09 | Wyeth | PTP1b inhibitors |
| CN103070854A (zh) | 2006-06-27 | 2013-05-01 | 武田药品工业株式会社 | 稠环化合物 |
| ES2488922T3 (es) | 2006-09-29 | 2014-09-01 | Idenix Pharmaceuticals, Inc. | Fosfoindoles enantiómeramente puros como inhibidores del HIV |
| KR20100134686A (ko) * | 2008-04-24 | 2010-12-23 | 인데나 에스.피.에이 | 만성염증을 갖는 질 감염의 치료를 위한 조성물 |
| US9840515B2 (en) | 2010-12-09 | 2017-12-12 | University of Pittsburgh—of the Commonwealth System of Higher Education | Protein kinase D inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4013641A (en) * | 1975-10-08 | 1977-03-22 | Xerox Corporation | Indolobenzoxazepines |
| WO1994017075A1 (en) * | 1993-01-20 | 1994-08-04 | A. Menarini Industrie Farmaceutiche Riunite S.R.L. | Diazepin derivatives and antiviral compositions |
| US5612330A (en) * | 1994-03-07 | 1997-03-18 | Warner-Lambert Company | Methods for inhibiting and controlling viral growth |
| US5489586A (en) * | 1994-03-07 | 1996-02-06 | Warner-Lambert Company | Method for treating inflammatory disease in humans |
-
1995
- 1995-03-22 US US08/408,431 patent/US5612330A/en not_active Expired - Fee Related
-
1996
- 1996-01-26 ES ES96903713T patent/ES2222477T3/es not_active Expired - Lifetime
- 1996-01-26 EP EP96903713A patent/EP0817635B1/en not_active Expired - Lifetime
- 1996-01-26 MX MX9705709A patent/MX9705709A/es not_active IP Right Cessation
- 1996-01-26 WO PCT/US1996/001098 patent/WO1996029077A1/en active IP Right Grant
- 1996-01-26 PT PT96903713T patent/PT817635E/pt unknown
- 1996-01-26 CA CA002211179A patent/CA2211179A1/en not_active Abandoned
- 1996-01-26 DE DE69632726T patent/DE69632726T2/de not_active Expired - Fee Related
- 1996-01-26 AT AT96903713T patent/ATE269084T1/de not_active IP Right Cessation
- 1996-01-26 JP JP8528389A patent/JPH11502814A/ja not_active Ceased
- 1996-01-26 DK DK96903713T patent/DK0817635T3/da active
- 1996-09-11 US US08/712,063 patent/US5703069A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996029077A1 (en) | 1996-09-26 |
| DK0817635T3 (da) | 2004-09-27 |
| ATE269084T1 (de) | 2004-07-15 |
| US5703069A (en) | 1997-12-30 |
| EP0817635B1 (en) | 2004-06-16 |
| JPH11502814A (ja) | 1999-03-09 |
| ES2222477T3 (es) | 2005-02-01 |
| MX9705709A (es) | 1997-10-31 |
| DE69632726T2 (de) | 2004-10-14 |
| US5612330A (en) | 1997-03-18 |
| EP0817635A1 (en) | 1998-01-14 |
| CA2211179A1 (en) | 1996-09-26 |
| DE69632726D1 (de) | 2004-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT817635E (pt) | Utilizacao de compostos de tiazepina e oxazepina para a inibicao do vih, herpesvirus e supressores do sitema imunitario | |
| DE69619279T2 (de) | Wegwerfhöschen | |
| FR2709415B1 (fr) | Culotte périodique jetable. | |
| CO4950529A1 (es) | Dihidropirimidinas y productos que las contienen | |
| NO1999006I1 (no) | Raloxifen | |
| CY2436B1 (en) | Medicament for treating cardiac inflammatory disease. | |
| AP9801346A0 (en) | Xanthone analogs for the treatment of infectious diseases | |
| NO903449D0 (no) | Fremgangsmaate for aa behandle underjordiske formasjoner. | |
| PT935684E (pt) | Luva reforcada e metodo e aparelho para formar a mesma | |
| AU4376396A (en) | Use of andrographolide compounds to treat or prevent pathogenicity of diseases | |
| EP0869801A4 (en) | THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS | |
| NO974034D0 (no) | Anatomisk formet, sammensatt sanitetsbind | |
| TW327171B (en) | 2-heteroaryl-5 for prevention or treatment of HIV infection | |
| ES2162919T3 (es) | Piridilbisfosfonatos para uso como agente terapeutico. | |
| ZA96722B (en) | Combination therapy for hiv infection | |
| AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
| CY2339B1 (en) | Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections. | |
| ES2194225T3 (es) | Regeneracion morfogenica inducida por peptidos de tejidos perceptores de sentidos. | |
| SE9301831D0 (sv) | Pharmaceutical compositions | |
| EP0655919A4 (en) | TREATMENT OF VIRAL INFECTIONS IN MAN. | |
| BR9612549A (pt) | Método para tratamento de agressão excessiva | |
| FR2699902B1 (fr) | Distributeur de feuillets repositionnables. | |
| FI943989A0 (fi) | Terapeuttisia tai ehkäiseviä aineita peroksilipidiin liittyviin sairauksiin | |
| ES1030501Y (es) | Apositivo rectal para tratamiento de las hemorroides. | |
| EP0624372A3 (en) | Medication for the treatment of HIV infections. |